Gan & Lee Pharmaceuticals Co Ltd (603087): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 66,34 Renminbi Yuan | 82,25 Renminbi Yuan | 51,02 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 83 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 597.432.169 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 4.052.146,96 | 3.045.347,804 | 2.608.036,95 | 1.712.270,496 | 3.612.043,826 | 3.361.881,875 | 2.895.062,095 | 2.387.386,515 | 2.370.529,473 | 1.771.493,418 | 1.219.808,711 | 926.600,711 | 692.641,596 |
Herstellungskosten | 978.951,762 | 777.145,342 | 724.704,181 | 443.931,481 | 399.896,092 | 309.819,713 | 237.975,035 | 187.067,444 | 206.629,826 | 166.366,78 | 109.499,322 | 83.634,25 | 67.411,432 |
Bruttoergebnis | 3.073.195,198 | 2.268.202,462 | 1.883.332,769 | 1.268.339,015 | 3.212.147,734 | 3.052.062,162 | 2.657.087,06 | 2.200.319,071 | 2.163.899,647 | 1.605.126,638 | 1.110.309,389 | 842.966,461 | 625.230,164 |
▸ Brutto-Marge | 75,84% | 74,48% | 72,21% | 74,07% | 88,93% | 90,78% | 91,78% | 92,16% | 91,28% | 90,61% | 91,02% | 90,97% | 90,27% |
Betriebliche Aufwendungen | 2.279.562,857 | 1.636.662,31 | 1.568.046,784 | 1.837.211,788 | 1.513.236,67 | 1.599.157,649 | 1.259.181,822 | 1.086.232,129 | 894.208,694 | 705.125,723 | 588.188,369 | 495.712,757 | 391.354,344 |
Operativer Gewinn/Verlust | 793.632,341 | 631.540,152 | 315.285,985 | -568.872,773 | 1.698.911,064 | 1.452.904,513 | 1.397.905,238 | 1.114.086,942 | 1.269.690,953 | 900.000,915 | 522.121,02 | 347.253,704 | 233.875,82 |
▸ Operative Marge | 19,59% | 20,74% | 12,09% | -33,22% | 47,03% | 43,22% | 48,29% | 46,67% | 53,56% | 50,8% | 42,8% | 37,48% | 33,77% |
Zinsen (Netto) | 84.911,528 | 91.914,064 | 76.322,121 | 96.681,572 | 177.605,053 | 311,95 | -2.850,764 | -946,096 | -481,428 | - | - | - | - |
▸ Zinsausgaben | 231,142 | 291,866 | 1.353,243 | 2.377,166 | 4.300,25 | 3.825,291 | 3.397,979 | 1.201,756 | 1.193,478 | - | - | - | - |
▸ Zinseinnahmen | 85.142,67 | 92.205,93 | 77.675,364 | 99.058,738 | 181.905,303 | 4.137,241 | 547,215 | 255,66 | 712,05 | - | - | - | - |
Andere Ausgaben | -351.261,874 | 93.069,064 | 85.467,026 | 110.281,752 | 180.503,559 | 7.746,166 | -2.414,99 | -382,586 | 1.279,579 | -6.808,095 | -3.632,82 | -7.965,12 | -7.581,267 |
Gewinn vor Steuern | 1.229.805,744 | 630.385,152 | 306.141,08 | -582.472,953 | 1.696.012,558 | 1.445.470,297 | 1.397.469,464 | 1.113.523,432 | 1.267.929,946 | 906.809,01 | 525.753,84 | 355.218,824 | 241.457,087 |
Steueraufwand | - | 15.721,347 | -34.090,412 | -142.956,574 | 243.257,909 | 214.759,594 | 230.188,724 | 179.558,194 | 187.975,635 | 137.190,809 | 78.358,849 | 50.163,717 | 36.733,905 |
Minderheitenanteil | 86.222,141 | -0,041 | 162,923 | -0,022 | -0,216 | -0,072 | -0,069 | -0,069 | -3,987 | -13,742 | -28,194 | -161,961 | -3,169 |
Nettogewinn/-verlust | 1.143.583,603 | 614.663,846 | 340.068,569 | -439.516,357 | 1.452.754,865 | 1.230.710,775 | 1.167.280,809 | 933.965,307 | 1.079.958,298 | 769.631,943 | 447.423,185 | 305.217,068 | 204.726,351 |
▸ Netto-Marge | 28,22% | 20,18% | 13,04% | -25,67% | 40,22% | 36,61% | 40,32% | 39,12% | 45,56% | 43,45% | 36,68% | 32,94% | 29,56% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.